Syros Pharmaceuticals Inc.

NAS: SYRS

GO
/marketstate/country/us

Market open

 --Real time quotes

Oct 4, 2022, 11:51 a.m.

/zigman2/quotes/201168308/composite

$

6.47

Change

+0.53 +8.92%

Volume

Volume 78,527

Real time quotes

/zigman2/quotes/201168308/composite

Previous close

$ 5.94

$ 6.47

Change

+0.53 +8.92%

Day low

Day high

$6.16

$6.47

Open

52 week low

52 week high

$5.25

$48.00

Open

Mark J. Alles

Presently, Mark J. Alles holds the position of President for Acetylon Pharmaceuticals, Inc. He is also on the board of 5 other companies.

He previously held the position of Chairman of Turning Point Therapeutics, Inc., Chairman & Chief Executive Officer for Celgene Corp., Principal at Centocor, Inc., Principal at Bayer Corp. and Vice President-Oncology Business Unit at Aventis Pharmaceuticals, Inc.

Mark J. Alles received an undergraduate degree from Lock Haven University of Pennsylvania.

Transactions

Date Shares Transaction Value
05/13/2020 10,000   Acquisition at $8.86 per share. 88,600

Officers and Executives

Dr. Nancy A. Simonian
President, Chief Executive Officer & Director
Mr. Jason Haas
Chief Financial Officer
Dr. Eric R. Olson
Chief Scientific Officer
Dr. David A. Roth
Chief Medical Officer
Ms. Kristin Stephen
Chief Development Officer
Mr. Conley Chee
Chief Commercial Officer
Dr. Richard A. Young
Director
Mr. Peter Wirth
Chairman
Mr. Mark J. Alles
Independent Director
Dr. S. Gail Eckhardt
Independent Director
Dr. Deborah L. Dunsire
Independent Director
Dr. Phillip A. Sharp
Independent Director
Ms. Marsha H. Fanucci
Independent Director
Dr. Amir H. Nashat
Independent Director
Dr. Srinivas Akkaraju
Independent Director
Link to MarketWatch's Slice.